Company profile for YourChoice Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

YourChoice Therapeutics is an early-stage biopharmaceutical company based in San Francisco. The company is dedicated to developing the first hormone-free birth control pill for men. Their lead candidate, YCT-529, is currently undergoing a phase one clinical trial. In preclinical studies, YCT-529 demonstrated efficacy comparable to or better than traditional female birth control pills. YourChoice Therapeutics aims to apply its ...
YourChoice Therapeutics is an early-stage biopharmaceutical company based in San Francisco. The company is dedicated to developing the first hormone-free birth control pill for men. Their lead candidate, YCT-529, is currently undergoing a phase one clinical trial. In preclinical studies, YCT-529 demonstrated efficacy comparable to or better than traditional female birth control pills. YourChoice Therapeutics aims to apply its patented therapeutic platform to develop hormone-free family planning products for women in future programs. The company was established in 2018 and received a $15 million Series A investment in 2022.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
San Francisco, CA 94103
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250722147991/en/YourChoice-Therapeutics-announces-second-Nature-publication

BUSINESSWIRE
22 Jul 2025

https://www.quotientsciences.com/news/yourchoice-therapeutics-publishes-data-phase-1a-yct-529-study-conducted-quotient-sciences

PRESS RELEASE
22 Jul 2025

https://www.businesswire.com/news/home/20250313578230/en/YourChoice-Therapeutics-Announces-Nature-Publication

BUSINESSWIRE
13 Mar 2025

https://www.businesswire.com/news/home/20240924791648/en

BUSINESSWIRE
24 Sep 2024

https://www.businesswire.com/news/home/20240603886060/en

BUSINESSWIRE
03 Jun 2024

https://www.accesswire.com/846988/male-contraceptive-initiative-marks-womens-history-month-with-investment-in-birth-control-pill-for-men

ACCESSWIRE
27 Mar 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty